1-11 of 11
John R. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation

Geoffrey Kim, Amy E. McKee, Yang-Min Ning, Maitreyee Hazarika, Marc Theoret, John R. Johnson, Qiang Casey Xu, Shenghui Tang, Rajeshwari Sridhara, Xiaoping Jiang, Kun He, Donna Roscoe, W. David McGuinn, Whitney S. Helms, Anne Marie Russell, Sarah Pope Miksinski, Jeanne Fourie Zirkelbach, Justin Earp, Qi Liu, Amna Ibrahim, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 4994–5000.
https://doi.org/10.1158/1078-0432.CCR-14-0776
Published: 30 September 2014
View articletitled, FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation
Open the PDF for FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation in another window
Journal Articles

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder S. Mann, John R. Johnson, Kun He, Rajeshwari Sridhara, Sophia Abraham, Brian P. Booth, Leigh Verbois, David E. Morse, Josephine M. Jee, Sarah Pope, Ravi S. Harapanhalli, Ramzi Dagher, Ann Farrell, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2318–2322.
https://doi.org/10.1158/1078-0432.CCR-06-2672
Published: 16 April 2007
View articletitled, Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
Open the PDF for Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma in another window
Journal Articles

Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma

Martin H. Cohen, John R. Johnson, Tristan Massie, Rajeshwari Sridhara, W. David McGuinn, Jr., Sophia Abraham, Brian P. Booth, M. Anwar Goheer, David Morse, Xiao H. Chen, Nallaperumal Chidambaram, Leslie Kenna, Jogarao V. Gobburu, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5329–5335.
https://doi.org/10.1158/1078-0432.CCR-06-0606
Published: 25 September 2006
View articletitled, Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
Open the PDF for Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma in another window
Journal Articles

Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Martin H. Cohen, John R. Johnson, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 6767–6771.
https://doi.org/10.1158/1078-0432.CCR-05-0722
Published: 03 October 2005
View articletitled, Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Open the PDF for Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme in another window
Journal Articles

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin Cohen, Rajeshwari Sridhara, Yeh-Fong Chen, Gene M. Williams, John Duan, Jogarao Gobburu, Brian Booth, Kimberly Benson, John Leighton, Li Shan Hsieh, Nallalerumal Chidambaram, Paul Zimmerman, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6414–6421.
https://doi.org/10.1158/1078-0432.CCR-05-0790
Published: 15 September 2005
View articletitled, Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen
Open the PDF for Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen in another window
Journal Articles

Letrozole in the Extended Adjuvant Treatment of Postmenopausal Women with History of Early-Stage Breast Cancer Who Have Completed 5 Years of Adjuvant Tamoxifen

Bhupinder S. Mann, John R. Johnson, Roswitha Kelly, Rajeshwari Sridhara, Grant Williams, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5671–5677.
https://doi.org/10.1158/1078-0432.CCR-05-0354
Published: 22 August 2005
View articletitled, Letrozole in the Extended Adjuvant Treatment of Postmenopausal Women with History of Early-Stage Breast Cancer Who Have Completed 5 Years of Adjuvant Tamoxifen
Open the PDF for Letrozole in the Extended Adjuvant Treatment of Postmenopausal Women with History of Early-Stage Breast Cancer Who Have Completed 5 Years of Adjuvant Tamoxifen in another window
Journal Articles

Pemetrexed in Malignant Pleural Mesothelioma

Maitreyee Hazarika, Robert M. White, Jr., Brian P. Booth, Yong-Cheng Wang, Doo Y. Lee Ham, Cheng Yi Liang, Atiqur Rahman, Jogarao V.S. Gobburu, Ning Li, Rajeshwari Sridhara, David E. Morse, Richard Lostritto, Patricia Garvey, John R. Johnson, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 982–992.
https://doi.org/10.1158/1078-0432.982.11.3
Published: 11 February 2005
View articletitled, Pemetrexed in Malignant Pleural Mesothelioma
Open the PDF for Pemetrexed in Malignant Pleural Mesothelioma in another window
Journal Articles

U.S. Food and Drug Administration Drug Approval Summary: Conversion of Imatinib Mesylate (STI571; Gleevec) Tablets from Accelerated Approval to Full Approval

Martin H. Cohen, John R. Johnson, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 12–19.
https://doi.org/10.1158/1078-0432.12.11.1
Published: 21 January 2005
View articletitled, U.S. Food and Drug Administration Drug Approval Summary: Conversion of Imatinib Mesylate (STI571; Gleevec) Tablets from Accelerated Approval to Full Approval
Open the PDF for U.S. Food and Drug Administration Drug Approval Summary: Conversion of Imatinib Mesylate (STI571; Gleevec) Tablets from Accelerated Approval to Full Approval in another window
Journal Articles

Approval Summary: Imatinib Mesylate Capsules for Treatment of Adult Patients with Newly Diagnosed Philadelphia Chromosome-positive Chronic Myelogenous Leukemia in Chronic Phase

John R. Johnson, Peter Bross, Martin Cohen, Mark Rothmann, Gang Chen, Anne Zajicek, Joga Gobburu, Atiqur Rahman, Ann Staten, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 1972–1979.
Published: 01 June 2003
View articletitled, Approval Summary: Imatinib Mesylate Capsules for Treatment of Adult Patients with Newly Diagnosed Philadelphia Chromosome-positive Chronic Myelogenous Leukemia in Chronic Phase
Open the PDF for Approval Summary: Imatinib Mesylate Capsules for Treatment of Adult Patients with Newly Diagnosed Philadelphia Chromosome-positive Chronic Myelogenous Leukemia in Chronic Phase in another window
Journal Articles

Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia

Martin H. Cohen, Grant Williams, John R. Johnson, John Duan, Jogarao Gobburu, Atiqur Rahman, Kimberly Benson, John Leighton, Sung K. Kim, Rebecca Wood, Mark Rothmann, Gang Chen, Khin Maung U, Ann M. Staten, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 935–942.
Published: 01 May 2002
View articletitled, Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia
Open the PDF for Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia in another window
Journal Articles

Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer

Martin H. Cohen, John R. Johnson, Ning Li, Gang Chen, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 665–669.
Published: 01 March 2002
View articletitled, Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer
Open the PDF for Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer in another window